ArticleHealth policy OPEN2022
Challenges and difficulties faced in low- and middle-income countries during COVID-19.
Article in Health policy OPEN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Dynamic Changes and Future Trend Forecasts in the Global Burden of Guillain-Barré Syndrome: Analysis of 204 Countries and Regions From 1990 to 2021, Including the Impact of the COVID-19 Pandemic.Immunity, inflammation and disease · 2026Observational
- Collaboration Between local health authorities and community leaders in health emergency response in low- and middle-income countries: a scoping review of evidence from the COVID-19 era.Archives of public health = Archives belges de sante publique · 2026Article
- Article
- Internationally studied parameters related to the COVID-19 pandemic in nursing homes: a scoping review.Systematic reviews · 2026Article
- Collaborations between local health authorities and community leaders in responding to health emergencies in low- and-middle-income countries: a scoping review protocol.Systematic reviews · 2025Article
- Responding to the covid-19 in west bank Palestine refugee camps: lessons and role of community engagement.BMC public health · 2025Article
- Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data.JMIR research protocols · 2025Article
- Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana.Vaccines · 2025Article
- High coverage and equitable distribution of COVID-19 vaccine uptake in two vulnerable areas in Bangladesh.PLOS global public health · 2025Article
- Religious affiliation and perceptions of healthcare access during and after COVID-19 in Poland.Frontiers in public health · 2025Article
- Intersectoral collaboration and health system resilience during COVID-19: learnings from Ahmedabad, India.Health policy and planning · 2024Article
- Article
- Vaccine inequity: a threat to Africa's recovery from COVID-19.Tropical medicine and health · 2023Review
- The challenges brought by the COVID-19 pandemic to health systems exposed pre-existing gaps.Health policy OPEN · 2023Article
- Article
- Antibiotic resistance and the COVID-19 pandemic: A dual crisis with complex challenges in LMICs.Health science reports · 2023Article
- Beyond the surface: accounting for confounders in understanding the link between collectivism and COVID-19 pandemic in the United States.BMC public health · 2023Article
- COVID-19 vaccination and governance in the case of low, middle and high-income countries.BMC public health · 2023Article
- Factors influencing plasma donation behavior of COVID-19 recovered patients in Bangladesh: A pilot study.Health science reports · 2023Article
- Burden of COVID-19 on health and wellbeing, education, and economy of Bangladesh.Clinical case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The ongoing COVID-19 pandemic, caused by a novel coronavirus SARS-CoV-2, has created a severe threat to global human health. We are extremely lucky because within the first year of the COVID-19 pandemic, scientists developed a number of vaccines against COVID-19. In this paper, the authors discuss the difficulties and challenges faced in different low-and middle-income countries due to the ongoing pandemic. Study design and methods: This research is primarily based on secondary data and existing literature reviews. The authors use maps and graphical representations to show information about vaccination coverage. Results: The lacking vaccination coverage and insufficient supply of oxygen tanks in hospitals of low- and middle-income countries (LMICs) raise the likelihood of death of the critical COVID-19 patients. Developed countries vaccinate their citizens more quickly than LMICs. In comparison to wealthy countries, LMICs usually lack the resources and capacity to obtain the required vaccination doses. Conclusion: It is frequently observed that hospitals in low- and middle-income nations with a dearth of oxygen tanks result in increased suffering and mortality. To avoid a worldwide disaster, LMICs urgently require COVID-19 vaccinations since viruses have no borders, and no one is safe until every one is protected in our interconnected world. Therefore, more national and international collaborative supports are urgently necessary for LMICs in this regard.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.